Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2004]
News [3351]
Articles [144]
Editorials [3]
Conferences [125]
elearning [18]
Prognostic tool could help clinicians identify high-risk cancer patients
Prognostic tool could help clinicians identify high-risk cancer patients
ASH 2025: Researchers identify CD40 as potential biomarker for a type of nodal T cell lymphoma
ASH 2025: Researchers identify CD40 as potential biomarker for a type of nodal T cell lymphoma
ASH 2025: Results show long-lasting benefits of CAR T cell therapy for hard-to-treat lymphoma
ASH 2025: Results show long-lasting benefits of CAR T cell therapy for hard-to-treat lymphoma
ASH 2025: Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially preventable
ASH 2025: Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially...
ASH 2025: Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukaemia patients eligible for intensive chemotherapy
ASH 2025: Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukaemia patients...
CDT1 overexpression suppresses DNA replication and induces DNA damage, suggesting a mechanism for cancer development
CDT1 overexpression suppresses DNA replication and induces DNA damage, suggesting a mechanism for cancer...
New tool reveals hidden metabolic weakness in blood cancers
New tool reveals hidden metabolic weakness in blood cancers
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
ASH 2025: Protective regimen allows successful stem cell transplant even without close genetic match between donor...
ASH 2025: CAR T cell therapy shows promising phase II trial results in multiple myeloma
ASH 2025: CAR T cell therapy shows promising phase II trial results in multiple myeloma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation